An update on atezolizumab for hepatocellular carcinoma

Ielasi, I; Sansone, V; Forgione, A; Granito, A; Benevento, F; Tovoli, F

Tovoli, F (corresponding author), IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Via Albertoni 15, I-40138 Bologna, BO, Italy.

DRUGS OF TODAY, 2021; 57 (6): 365

Abstract

Hepatocellular carcinoma (HCC) is a worldwide problem, with a high prevalence in nonindustrialized countries and a rising incidence in industrialized ......

Full Text Link